Quotient Limited to Participate in the LEERINK Partners 7th Annual Global Healthcare Conference

JERSEY, Channel Islands, Jan. 31, 2018 -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that the Company's Chairman and Chief Executive Officer, Paul Cowan, will present at the LEERINK Partners 7^th Annual Global Healthcare Conference on Wednesday, February 14^th, 2018 at 1:30 p.m. EST at the Lotte New York Palace Hotel, in New York, NY. The Company's Chief Financial Officer, Chris Lindop, will also be participating in the conference.

A webcast of the presentation will be available online from the investor relations page of the Company's corporate website at www.quotientbd.com. A webcast replay will be archived on the website for approximately 90 days.

About Quotient Limited

Quotient is a commercial-stage diagnostics company committed to reducing healthcare costs and improving patient care through the provision of innovative tests within established markets. With an initial focus on blood grouping and serological disease screening, Quotient is developing its proprietary MosaiQ™ technology platform to offer a breadth of tests that is unmatched by existing commercially available transfusion diagnostic instrument platforms. The company's operations are based in Edinburgh, Scotland; Eysins, Switzerland and Newtown, Pennsylvania.

The Quotient logo and MosaiQ™ are registered trademarks or trademarks of Quotient Limited and its subsidiaries in various jurisdictions.

CONTACT:  Chris Lindop, Chief Financial Officer — [email protected]; +41 (0)799 61 69 38